This document is a stock and sales report for Matrix Pharma-Chem (India) Pvt between August 1-31, 2019. It details the opening and closing quantities and values for various drugs and medical products, as well as receipts and sales during the period. Key products include Equipod CV 325 Tablets, Onpar 650 Tablets, Pogomox CV 625 Tablets, and Totalvit Tablets. The total receipts for the period were Rs. 270,052.55, total sales were Rs. 321,044.89, and closing stock value was Rs. 40,464.73.
This document is a stock and sales report for Matrix Pharma-Chem (India) Pvt between August 1-31, 2019. It details the opening and closing quantities and values for various drugs and medical products, as well as receipts and sales during the period. Key products include Equipod CV 325 Tablets, Onpar 650 Tablets, Pogomox CV 625 Tablets, and Totalvit Tablets. The total receipts for the period were Rs. 270,052.55, total sales were Rs. 321,044.89, and closing stock value was Rs. 40,464.73.
This document is a stock and sales report for Matrix Pharma-Chem (India) Pvt between August 1-31, 2019. It details the opening and closing quantities and values for various drugs and medical products, as well as receipts and sales during the period. Key products include Equipod CV 325 Tablets, Onpar 650 Tablets, Pogomox CV 625 Tablets, and Totalvit Tablets. The total receipts for the period were Rs. 270,052.55, total sales were Rs. 321,044.89, and closing stock value was Rs. 40,464.73.
This document is a stock and sales report for Matrix Pharma-Chem (India) Pvt between August 1-31, 2019. It details the opening and closing quantities and values for various drugs and medical products, as well as receipts and sales during the period. Key products include Equipod CV 325 Tablets, Onpar 650 Tablets, Pogomox CV 625 Tablets, and Totalvit Tablets. The total receipts for the period were Rs. 270,052.55, total sales were Rs. 321,044.89, and closing stock value was Rs. 40,464.73.